Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32
United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert I Blum
15 Sep 2026
President & CEO
Sold on a plan indirect
97,926
$69.33
$6.79M
Robert E Landry
15 Sep 2026
Director
Sold on a plan
1,000
$72.13
$72.13K
Robert E Landry
11 Sep 2026
Director
Sold on a plan
1,000
$74.66
$74.66K
B Lynne Parshall
1 Sep 2026
Director
Sold on a plan
5,000
$71.48
$357.40K
Robert I Blum
1 Jul 2026
President & CEO
Sold on a plan
7,500
$84.92
$636.90K
Robert I Blum
15 Jun 2026
President & CEO
Sold on a plan
7,500
$70.46
$528.45K
B Lynne Parshall
1 Jun 2026
Director
Sold on a plan
5,000
$74.08
$370.40K
Edward M. MD Kaye
1 Jun 2026
Director
Sold on a plan
2,933
$76.09
$223.17K
Robert I Blum
27 May 2026
President & CEO
Sold on a plan
7,500
$77.21
$579.08K
Robert I Blum
14 May 2026
President & CEO
Sold on a plan
7,500
$77.92
$584.40K
Sung Lee
5 May 2026
EVP, Chief Financial Officer
Sold on a plan
23,906
$76.87
$1.84M
Robert I Blum
29 Apr 2026
President & CEO
Sold on a plan
7,500
$59.62
$447.15K
Robert I Blum
15 Apr 2026
President & CEO
Sold on a plan
7,500
$65.38
$490.35K
Andrew Callos
15 Apr 2026
EVP, Chief Commercial Officer
Sold on a plan
7,449
$66.02
$491.78K
Robert I Blum
1 Apr 2026
President & CEO
Sold on a plan
7,500
$66.63
$499.73K
Andrew Callos
31 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
3,639
$65.00
$236.54K
Andrew Callos
18 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
1,930
$62.07
$119.80K
Andrew Callos
16 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
1,709
$61.03
$104.30K
B Lynne Parshall
2 Mar 2026
Director
Sold on a plan
5,000
$61.21
$306.05K
Andrew Callos
29 Dec 2025
EVP, Chief Commercial Officer
Sold on a plan
1,809
$62.44
$112.95K
Robert Arthur Harrington
1 Dec 2025
Director
Sold on a plan
2,150
$66.80
$143.62K
B Lynne Parshall
19 Nov 2025
Director
Sold on a plan
5,000
$64.73
$323.65K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 53
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,087,174
History held since 3 Oct 2006